NovoCure (NASDAQ:NVCR – Get Free Report) will announce its earnings results before the market opens on Thursday, July 25th. Analysts expect the company to announce earnings of ($0.40) per share for the quarter. Investors interested in participating in the company’s conference call can do so using this link.
NovoCure (NASDAQ:NVCR – Get Free Report) last announced its quarterly earnings data on Thursday, May 2nd. The medical equipment provider reported ($0.36) earnings per share for the quarter, topping the consensus estimate of ($0.43) by $0.07. The firm had revenue of $138.50 million during the quarter, compared to analysts’ expectations of $131.44 million. NovoCure had a negative return on equity of 50.35% and a negative net margin of 36.67%. The company’s quarterly revenue was up 13.3% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.50) EPS. On average, analysts expect NovoCure to post $-2 EPS for the current fiscal year and $-2 EPS for the next fiscal year.
NovoCure Price Performance
NovoCure stock opened at $18.77 on Wednesday. The firm has a market capitalization of $2.02 billion, a P/E ratio of -10.37 and a beta of 0.70. NovoCure has a 1 year low of $10.87 and a 1 year high of $41.51. The business has a 50-day moving average of $20.01 and a 200-day moving average of $16.47. The company has a current ratio of 6.26, a quick ratio of 5.99 and a debt-to-equity ratio of 1.59.
Analysts Set New Price Targets
Get Our Latest Report on NovoCure
About NovoCure
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua.
Recommended Stories
- Five stocks we like better than NovoCure
- 3 REITs to Buy and Hold for the Long Term
- ScottsMiracle-Gro Stock Blooms After Investor Day Optimism
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Leading Beverage Company’s Stock Bubbles Higher: Rally Ahead
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Can This Meme Stock Stage One Last Rally?
Receive News & Ratings for NovoCure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovoCure and related companies with MarketBeat.com's FREE daily email newsletter.